Elevated fasting insulin predicts the future incidence of metabolic syndrome: A 5-year follow-up study

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Sung, Ki Chul C ^a   Seo, Mi Hae H ^a   Rhee, Eun Jung J ^a   Wilson, Andrew M ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Hyperinsulinemia; Insulin resistance; Metabolic syndrome

Indexed keywords

GLUCOSE; INSULIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; DISEASE ASSOCIATION; FASTING INSULIN LEVEL; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PREDICTION; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; BLOOD; CHI SQUARE DISTRIBUTION; DIET RESTRICTION; HYPERINSULINISM; INCIDENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; RISK ASSESSMENT; SOUTH KOREA; STATISTICAL MODEL; TIME; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERINSULINISM; INCIDENCE; INSULIN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 82255195357     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-108     Document Type: Article

References (39)

1. Grundy SM. Does a diagnosis of metabolic syndrome have value in clinical practice?. Am J Clin Nutr 2006, 83:1248-1251.
2. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645. 10.1161/CIRCULATIONAHA.109.192644, 19805654.
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752. 10.1161/CIRCULATIONAHA.105.169404, 16157765.
4. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607. 10.2337/diabetes.37.12.1595, 3056758.
5. Reaven GM. The metabolic syndrome: time to get off the merry-go-round?. J Intern Med 2011, 269:127-136. 10.1111/j.1365-2796.2010.02325.x, 21129047.
6. Lee HT, Shin J, Lim YH, Kim BK, Kim YT, Lee JU, Hong S, Song SY, Cho SH. The relationship between coronary artery calcification and bone mineral density in patients according to their metabolic syndrome status. Korean Circ J 2011, 41:76-82. 10.4070/kcj.2011.41.2.76, 3053564, 21430992.
7. Lim JH, Kim YK, Kim YS, Na SH, Rhee MY, Lee MM. Relationship between serum uric Acid levels, metabolic syndrome, and arterial stiffness in Korean. Korean Circ J 2010, 40:314-320. 10.4070/kcj.2010.40.7.314, 2910287, 20664739.
8. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005, 365:1415-1428. 10.1016/S0140-6736(05)66378-7, 15836891.
9. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajkovich Mirchov I, Ben-Nakhi A, Reaven G, Hama Sambo B, Mendis S, Roglic G. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia 2010, 53:600-605. 10.1007/s00125-009-1620-4, 20012011.
10. Hermans MP, Sacks FM, Ahn SA, Rousseau MF. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence. Cardiovasc Diabetol 2011, 10:20. 10.1186/1475-2840-10-20, 3056766, 21356116.
11. Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989, 320:702-706. 10.1056/NEJM198903163201105, 2646537.
12. Ferrannini E, Balkau B, Coppack SW, Dekker JM, Mari A, Nolan J, Walker M, Natali A, Beck-Nielsen H. Insulin resistance, insulin response, and obesity as indicators of metabolic risk. J Clin Endocrinol Metab 2007, 92:2885-2892. 10.1210/jc.2007-0334, 17504904.
13. Kim SH, Reaven GM. Insulin resistance and hyperinsulinemia: you can't have one without the other. Diabetes Care 2008, 31:1433-1438. 10.2337/dc08-0045, 2453638, 18594063.
14. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech 2009, 2:231-237. 10.1242/dmm.001180, 2675814, 19407331.
15. Mehta NN, Krishnamoorthy P, Martin SS, St Clair C, Schwartz S, Iqbal N, Braunstein S, Schutta M, Rader DJ, Reilly MP. Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus. Am J Cardiol 2011, 107:406-411. 10.1016/j.amjcard.2010.09.035, 21257006.
16. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Duncan BB, Heiss G. Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Atherosclerosis risk in communities. Ann Epidemiol 1997, 7:407-416. 10.1016/S1047-2797(97)00047-1, 9279450.
17. Moebus S, Balijepalli C, Lösch C, Göres L, von Stritzky B, Bramlage P, Wasem J, Jöckel KH. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol 2010, 9:34. 10.1186/1475-2840-9-34, 2929217, 20696055.
18. Sung KC, Kim SH, Reaven GM. Relationship among alcohol, body weight, and cardiovascular risk factors in 27, 030 Korean men. Diabetes Care 2007, 30:2690-2694. 10.2337/dc07-0315, 17623829.
19. Sung KC, Ryan MC, Kim BS, Cho YK, Kim BI, Reaven GM. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Diabetes Care 2007, 30:2113-2118. 10.2337/dc07-0512, 17475935.
20. American Diabetes Association Standards of medical care in diabetes--2010. Diabetes Care 2010, 33:S11-S61. 2797382, 20042772, American Diabetes Association.
21. Rhee EJ, Lee WY, Cho YK, Kim BI, Sung KC. Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults. Am J Med 2011, 124:69-76. 10.1016/j.amjmed.2010.08.012, 21187187.
22. Sung KC, Kim SH. Interrelationship between Fatty Liver and Insulin Resistance in the Development of Type 2 Diabetes. J Clin Endocrinol Metab 2011, 96:1093-1097. 10.1210/jc.2010-2190, 21252243.
23. Sung KC, Reaven GM, Kim SH. Utility of homeostasis model assessment of beta-cell function in predicting diabetes in 12, 924 healthy Koreans. Diabetes Care 2010, 33:200-202. 10.2337/dc09-1070, 2797973, 19808927.
24. Song Y, Manson JE, Tinker L, Howard BV, Kuller LH, Nathan L, Rifai N, Liu S. Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study. Diabetes Care 2007, 30:1747-1752. 10.2337/dc07-0358, 1952235, 17468352.
25. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am 2008, 37:581-601. vii-viii, 10.1016/j.ecl.2008.06.005, 18775353.
26. Mykkänen L, Haffner SM, Rönnemaa T, Bergman RN, Laakso M. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol 1997, 146:315-321.
27. Abbasi F, Reaven GM. Evaluation of the quantitative insulin sensitivity check index as an estimate of insulin sensitivity in humans. Metabolism 2002, 51:235-237. 10.1053/meta.2002.28970, 11833054.
28. Kim SH, Abbasi F, Reaven GM. Impact of degree of obesity on surrogate estimates of insulin resistance. Diabetes Care 2004, 27:1998-2002. 10.2337/diacare.27.8.1998, 15277430.
29. Li WC, Hsiao KY, Chen IC, Chang YC, Wang SH, Wu KH. Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults. Cardiovasc Diabetol 2011, 10:36. 10.1186/1475-2840-10-36, 3098150, 21526991.
30. Morrison JA, Glueck CJ, Horn PS, Schreiber GB, Wang P. Homeostasis model assessment of insulin resistance*body mass index interactions at ages 9 to 10 years predict metabolic syndrome risk factor aggregate score at ages 18 to 19 years: a 10-year prospective study of black and white girls. Metabolism 2009, 58:290-295. 10.1016/j.metabol.2008.09.027, 19217441.
31. DeBoer MD, Gurka MJ. Ability among adolescents for the metabolic syndrome to predict elevations in factors associated with type 2 diabetes and cardiovascular disease: data from the national health and nutrition examination survey 1999-2006. Metab Syndr Relat Disord 2010, 8:343-353. 10.1089/met.2010.0008, 3046372,3046372, 20698802.
32. Benetos A, Thomas F, Pannier B, Bean K, Jego B, Guize L. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome. Am J Cardiol 2008, 102:188-191. 10.1016/j.amjcard.2008.03.037, 18602519.
33. Butler J, Mooyaart EA, Dannemann N, Bamberg F, Shapiro MD, Ferencik M, Brady TJ, Hoffmann U. Relation of the metabolic syndrome to quantity of coronary atherosclerotic plaque. Am J Cardiol 2008, 101:1127-1130. 10.1016/j.amjcard.2007.12.012, 2735397, 18394445.
34. Espinola-Klein C, Rupprecht HJ, Bickel C, Post F, Genth-Zotz S, Lackner K, Munzel T, Blankenberg S. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. Am J Cardiol 2007, 99:1623-1628. 10.1016/j.amjcard.2007.01.049, 17560864.
35. Ho JS, Cannaday JJ, Barlow CE, Mitchell TL, Cooper KH, FitzGerald SJ. Relation of the number of metabolic syndrome risk factors with all-cause and cardiovascular mortality. Am J Cardiol 2008, 102:689-692. 10.1016/j.amjcard.2008.05.010, 18773989.
36. Tenenbaum A, Adler Y, Boyko V, Tenenbaum H, Fisman EZ, Tanne D, Lapidot M, Schwammenthal E, Feinberg MS, Matas Z, Motro M, Behar S. Insulin resistance is associated with increased risk of major cardiovascular events in patients with preexisting coronary artery disease. Am Heart J 2007, 153:559-565. 10.1016/j.ahj.2007.01.008, 17383294.
37. Irie F, Iso H, Noda H, Sairenchi T, Otaka E, Yamagishi K, Doi M, Izumi Y, Ota H. Associations between metabolic syndrome and mortality from cardiovascular disease in Japanese general population, findings on overweight and non-overweight individuals. Ibaraki Prefectural Health Study. Circ J 2009, 73:1635-1642. 10.1253/circj.CJ-08-0442, 19590142.
38. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010, 56:1113-1132. 10.1016/j.jacc.2010.05.034, 20863953.
39. Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab 2000, 85:4426-4433. 10.1210/jc.85.12.4426, 11134088.